Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Neuroscience Letters|February 1, 2021
Treating viruses in the brain: Perspectives from NeuroAIDSMelanie R Nicol, MaryPeace McRae
Tissue Barriers|May 4, 2016
HIV and viral protein effects on the blood brain barrierMaryPeace McRae
American Journal of Pharmaceutical Education|March 22, 2019
Identifying Components of Success Within Health Sciences-Focused Mentoring Programs Through a Review of the LiteratureMaryPeace McRae, Kristin M Zimmerman
ASN Neuro|March 9, 2023
Casein Kinase 2 Mediates HIV- and Opioid-Induced Pathologic Phosphorylation of TAR DNA Binding Protein 43 in the Basal GangliaMichael Ohene-Nyako, Sara R Nass, Hope T Richard, et al.
The Journal of Infectious Diseases|June 20, 2024
Postmortem Analysis of Dolutegravir, Tenofovir, Lamivudine, and Efavirenz Penetration in Multiple Central Nervous System CompartmentsFan Wang, Kara Rademeyer, Olivie C Namuju, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|September 3, 2020
Opioid and neuroHIV Comorbidity - Current and Future PerspectivesSylvia Fitting, MaryPeace McRae, Kurt F Hauser
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|May 20, 2011
Safety, Tolerability, and Pharmacokinetics of KP-1461 in Phase I Clinical Studies: A Single Oral Dose Study in Non-HIV-Infected Adults, and a 14-Day Dose-Escalating Study in Highly Antiretroviral-Experienced HIV-Infected AdultsPatrick G Clay, Marypeace McRae, Jean-Pierre Laurent
Pharmacotherapy|July 30, 2009
Pharmacokinetics of concurrent administration of fosamprenavir and atazanavir without ritonavir in human immunodeficiency virus-negative subjectsMarypeace McRae, Patrick G Clay, Peter L Anderson, et al.
Current Infectious Disease Reports|September 21, 2017
New Drugs in the Pipeline for the Treatment of HIV: a ReviewLeigh Anne Hylton Gravatt, Crystal R Leibrand, Sulay Patel, et al.
AIDS Research and Human Retroviruses|September 13, 2022
Translational Models to Predict Target Concentrations for Pre-Exposure Prophylaxis in WomenAlyssa M Lantz, Melanie R Nicol
Pageof 9